4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alzheimer’s disease (AD) is a neurodegenerative disease with insidious onset and progressive development. It is clinically characterized by cognitive impairment, memory impairment and behavioral change. Chinese herbal medicine and acupuncture are important components of traditional Chinese medicine (TCM), and are commonly used in clinical treatment of AD. This paper systematically summarizes the research progress of traditional Chinese medicine natural products and acupuncture treatment of AD, which combined with existing clinical and preclinical evidence, based on a comprehensive review of neuroinflammation, and discusses the efficacy and potential mechanisms of traditional Chinese medicine natural products and acupuncture treatment of AD. Resveratrol, curcumin, kaempferol and other Chinese herbal medicine components can significantly inhibit the neuroinflammation of AD in vivo and in vitro, and are candidates for the treatment of AD. Acupuncture can alleviate the memory and cognitive impairment of AD by improving neuroinflammation, synaptic plasticity, nerve cell apoptosis and reducing the production and aggregation of amyloid β protein (Aβ) in the brain. It has the characteristics of early, safe, effective and benign bidirectional adjustment. The purpose of this paper is to provide a basis for improving the clinical strategies of TCM for the treatment of AD.

          Graphical Abstract

          Related collections

          Most cited references246

          • Record: found
          • Abstract: found
          • Article: not found

          The NLRP3 inflammasome: molecular activation and regulation to therapeutics

          NLRP3 (NACHT, LRR and PYD domains-containing protein 3) is an intracellular sensor that detects a broad range of microbial motifs, endogenous danger signals and environmental irritants, resulting in the formation and activation of the NLRP3 inflammasome. Assembly of the NLRP3 inflammasome leads to caspase-1-dependent release of the proinflammatory cytokines, IL-1β and IL-18, as well as to gasdermin D-mediated pyroptotic cell death. Recent studies have revealed new regulators of the NLRP3 inflammasome, including new interacting or regulatory proteins, metabolic pathways and a regulatory mitochondrial hub. In this Review, we present the molecular, cell biological and biochemical basis of NLRP3 activation and regulation, and describe how this mechanistic understanding is leading to potential therapeutics that target the NLRP3 inflammasome.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neuroinflammation in Alzheimer's disease.

            Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on microglia and astroglia, and trigger an innate immune response characterised by release of inflammatory mediators, which contribute to disease progression and severity. Genome-wide analysis suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction. External factors, including systemic inflammation and obesity, are likely to interfere with immunological processes of the brain and further promote disease progression. Modulation of risk factors and targeting of these immune mechanisms could lead to future therapeutic or preventive strategies for Alzheimer's disease. Copyright © 2015 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

              Alzheimer disease (AD) is the most common form of neurodegenerative disease, estimated to contribute 60-70% of all cases of dementia worldwide. According to the prevailing amyloid cascade hypothesis, amyloid-β (Aβ) deposition in the brain is the initiating event in AD, although evidence is accumulating that this hypothesis is insufficient to explain many aspects of AD pathogenesis. The discovery of increased levels of inflammatory markers in patients with AD and the identification of AD risk genes associated with innate immune functions suggest that neuroinflammation has a prominent role in the pathogenesis of AD. In this Review, we discuss the interrelationships between neuroinflammation and amyloid and tau pathologies as well as the effect of neuroinflammation on the disease trajectory in AD. We specifically focus on microglia as major players in neuroinflammation and discuss the spatial and temporal variations in microglial phenotypes that are observed under different conditions. We also consider how these cells could be modulated as a therapeutic strategy for AD.
                Bookmark

                Author and article information

                Contributors
                guoyi_168@163.com
                linxiaoweiwqhz@163.com
                Journal
                Chin Med
                Chin Med
                Chinese Medicine
                BioMed Central (London )
                1749-8546
                28 February 2024
                28 February 2024
                2024
                : 19
                : 35
                Affiliations
                [1 ]School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, ( https://ror.org/05dfcz246) Tianjin, 301617 People’s Republic of China
                [2 ]School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, ( https://ror.org/05dfcz246) Tianjin, 301617 People’s Republic of China
                [3 ]Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, ( https://ror.org/05dfcz246) Tianjin, 301617 People’s Republic of China
                [4 ]Tianjin Key Laboratory of Modern Chinese Medicine Theory of Innovation and Application, Tianjin, 301617 People’s Republic of China
                [5 ]GRID grid.410648.f, ISNI 0000 0001 1816 6218, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, ; Tianjin, 300381 People’s Republic of China
                [6 ]State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, ( https://ror.org/05dfcz246) Tianjin, 301617 China
                Author information
                http://orcid.org/0000-0002-4961-3073
                Article
                900
                10.1186/s13020-024-00900-6
                10900670
                38419106
                941b2f0b-26b8-43e1-9555-7e85ea657153
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 7 December 2023
                : 5 February 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81873369
                Award ID: 82030125
                Award ID: 82105024
                Award Recipient :
                Funded by: Tianjin Graduate Research Innovation Project
                Award ID: 2022BKY179
                Award Recipient :
                Funded by: TUTCM Graduate Research Innovation Project
                Award ID: YJSKC-20221020
                Award Recipient :
                Categories
                Review
                Custom metadata
                © International Society for Chinese Medicine and BioMed Central Ltd. 2024

                Complementary & Alternative medicine
                alzheimer’s disease,traditional chinese medicine natural products,acupuncture,efficacy and mechanism,neuroinflammation

                Comments

                Comment on this article